After more than 50 years as a quality control engineer and having worked with more than 700 companies, it is my observation that the vast majority of quality professionals hold their prime directive to be reducing defects to the lowest acceptable level by minimizing

In recent months, the widespread lockdowns of Covid-19 have exposed global supply chains to unprecedented shifts and volatility in consumer behavior, impacting innumerable organizations, industries, and consumer goods.

I recently read a Recruiterbox article that stated: “Culture can either immunize or infect a company. Good culture can revitalize and motivate.

Arguing against globalization is like arguing against the laws of gravity, said former United Nations

Product development (PD) is the life blood of a company’s success and is the process for innovation. Today, product life cycles are shrinking due to an ever-increasing number of competitive and disruptive products coming to market quicker.

The Covid-19 pandemic has revealed glaring deficiencies in the U.S. manufacturing sector’s ability to provide necessary products—especially amidst a crisis.

The reality for small and medium-sized manufacturers (SMMs) is that they are going to have to be good at training their workforce or they won’t make as much money.

Covid-19 has led to a boom in telehealth, with some healthcare facilities seeing an increase in its use by as much as 8,000 percent.

When it comes to quality management objectives, what many manufacturers don’t understand about cost of quality could hurt them.